Somite
Somite.ai is a venture-backed company aiming to become the OpenAI of stem cell biology, developing AI foundation models to produce human tissue for cell therapies at scale for diseases such as diabetes, obesity, and muscular dystrophies. Somite's AI platform, AlphaStem, fuels a virtuous cycle: It enables new cell therapies, generating massive data that further improve the platform, empowering even faster therapy creation with broader applications. The company's pipeline includes the promising SMT-M01 program for Duchenne muscular dystrophy (DMD) and the SMT-B01 program for metabolic disorders. Incorporated in Oct. 2023, Somite.ai has raised over $10m to date.
Domain
somite.ai
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
11-50
Last Funding
$47.5M
Founded
2023
Tech Stack (12 technologies)
Frequently Asked Questions
What technologies does Somite use?+
Somite uses 12 technologies including Google Font API, Webflow, Finsweet.
What industry is Somite in?+
Somite operates in the Artificial Intelligence (AI) industry.
Where is Somite based?+
Somite is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026